FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Robert Howland

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Procedures

Co-author Network

Publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Robert Howland (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: W Victor R Vieweg; Mehrul Hasnain; Robert H Howland
The reply.
The American journal of medicine 2013;126(6):e23.
2013: Robert H Howland
Ketamine for the treatment of depression.
Journal of psychosocial nursing and mental health services 2013;51(1):11-4.
2012: Robert H Howland
Future prospects for pharmacogenetics in the quest for personalized medicine.
Journal of psychosocial nursing and mental health services 2012;50(12):13-6.
2012: W Victor R Vieweg; Mark A Wood; Mehrul Hasnain; John M Hettema; Robert H Howland; Christopher Kogut; Anand K Pandurangi
Citalopram, QTc interval prolongation, and torsade de pointes. How should we apply the recent FDA ruling?
The American journal of medicine 2012;125(9):859-68.
2011: Robert H Howland
A benefit-risk assessment of agomelatine in the treatment of major depression.
Drug safety : an international journal of medical toxicology and drug experience 2011;34(9):709-31.
2011: Robert H Howland; Luann S Shutt; Susan R Berman; Crystal R Spotts; Timothey Denko
The emerging use of technology for the treatment of depression and other neuropsychiatric disorders.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2011;23(1):48-62.
2011: Robert H Howland
Vitamin D and depression.
Journal of psychosocial nursing and mental health services 2011;49(2):15-8.
2010: Robert H Howland
Use of endocrine hormones for treating depression.
Journal of psychosocial nursing and mental health services 2010;48(12):13-6.
2010: Robert H Howland
Potential adverse effects of discontinuing psychotropic drugs. Part 3: Antipsychotic, dopaminergic, and mood-stabilizing drugs.
Journal of psychosocial nursing and mental health services 2010;48(8):11-4.
2010: Robert H Howland
Therapeutic armamentarium for treating depression.
Postgraduate medicine 2010;122(4):66-93.
2010: Robert H Howland
Potential adverse effects of discontinuing psychotropic drugs. Part 1: Adrenergic, cholinergic, and histamine drugs.
Journal of psychosocial nursing and mental health services 2010;48(6):11-4.
2010: Robert H Howland
The diverse clinical uses of opioid receptor drugs.
Journal of psychosocial nursing and mental health services 2010;48(5):11-4.
2010: Robert H Howland
Are generic medications safe and effective?
Journal of psychosocial nursing and mental health services 2010;48(3):13-6.
2010: Robert H Howland
When is a "generic" medication not really a generic?
Journal of psychosocial nursing and mental health services 2010;48(2):13-6.
2010: Robert H Howland
Evaluating the bioavailability and bioequivalence of generic medications.
Journal of psychosocial nursing and mental health services 2010;48(1):13-6.
2009: Robert H Howland
What makes a generic medication generic?
Journal of psychosocial nursing and mental health services 2009;47(12):17-20.
2009: Robert H Howland
Understanding chirality and stereochemistry: three-dimensional psychopharmacology.
Journal of psychosocial nursing and mental health services 2009;47(7):15-8.
2009: Judith A Callan; Robert H Howland
Adolescent depression: assessment and treatment.
Journal of psychosocial nursing and mental health services 2009;47(7):11-2.
2009: Robert H Howland
The antidepressant effects of anticholinergic drugs.
Journal of psychosocial nursing and mental health services 2009;47(6):17-20.
2009: Robert H Howland
Prescribing psychotropic medications during pregnancy and lactation: principles and guidelines.
Journal of psychosocial nursing and mental health services 2009;47(5):19-23.
2009: Judith A Callan; Robert H Howland
Borderline personality disorder: inpatient psychiatric nursing management.
Journal of psychosocial nursing and mental health services 2009;47(5):13-4.
2009: Robert H Howland
Categorizing the safety of medications during pregnancy and lactation.
Journal of psychosocial nursing and mental health services 2009;47(4):17-20.
2009: Robert H Howland
Evaluating the safety of medications during pregnancy and lactation.
Journal of psychosocial nursing and mental health services 2009;47(3):19-22.
2009: Judith A Callan; Robert H Howland; Kathryn Puskar
Economic anxiety.
Journal of psychosocial nursing and mental health services 2009;47(3):13-4.
2009: Robert H Howland
What should patients be told about their medications?
Journal of psychosocial nursing and mental health services 2009;47(2):17-20.
2009: Robert H Howland
Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults.
Neuropsychiatric disease and treatment 2009;5():563-76.
2009: Robert H Howland
Pharmacogenetics and pharmacovigilance.
Drug safety : an international journal of medical toxicology and drug experience 2009;32(3):265-70.
2009: Robert H Howland
Somatic therapies for seasonal affective disorder.
Journal of psychosocial nursing and mental health services 2009;47(1):17-20.
2009: Judith A Callan; Robert H Howland; Kathryn Puskar
Using computers and the Internet for psychiatric nursing intervention.
Journal of psychosocial nursing and mental health services 2009;47(1):13-4.
2009: Robert H Howland; A John Rush; Stephen R Wisniewski; Madhukar H Trivedi; Diane Warden; Maurizio Fava; Lori Davis; Balasubramani G.K.; Patrick J McGrath; Susan R Berman
Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.
Drug and alcohol dependence 2009;99(1-3):248-60.
2008: Robert H Howland
Understanding the clinical profile of a drug on the basis of its pharmacology: mirtazapine as an example.
Journal of psychosocial nursing and mental health services 2008;46(12):19-23.
2008: Robert H Howland
Risks and benefits of antipsychotic drugs in elderly patients with dementia.
Journal of psychosocial nursing and mental health services 2008;46(11):19-23.
2008: Robert H Howland; Michael G Wilson; Susan G Kornstein; Anita H Clayton; Madhukar H Trivedi; Madelaine M Wohlreich; Maurizio Fava
Factors predicting reduced antidepressant response: experience with the SNRI duloxetine in patients with major depression.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 2008;20(4):209-18.
2008: Robert H Howland
Sequenced Treatment Alternatives to Relieve Depression (STAR*D). Part 2: Study outcomes.
Journal of psychosocial nursing and mental health services 2008;46(10):21-4.
2008: Robert H Howland
Sequenced Treatment Alternatives to Relieve Depression (STAR*D). Part 1: study design.
Journal of psychosocial nursing and mental health services 2008;46(9):21-4.
2008: Robert H Howland
Lisdexamfetamine: a prodrug stimulant for ADHD.
Journal of psychosocial nursing and mental health services 2008;46(8):19-22.
2008: Robert H Howland
Pharmacotherapy for psychotropic drug-related weight gain.
Journal of psychosocial nursing and mental health services 2008;46(7):15-8.
2008: Robert H Howland
Understanding the placebo effect. Part 2: underlying psychological & neurobiological processes.
Journal of psychosocial nursing and mental health services 2008;46(6):15-8.
2008: Robert H Howland
Understanding the placebo effect. Part 1: placebo use in clinical trials.
Journal of psychosocial nursing and mental health services 2008;46(5):17-20.
2008: Robert H Howland
The need to guard against pharmaceutical industry influence.
Psychiatric services (Washington, D.C.) 2008;59(5):566.
2008: Mark Stork George; Herbert E Ward; Philip T Ninan; Mark Pollack; Ziad Nahas; Berry Anderson; Samet Kose; Robert H Howland; Wayne K Goodman; James C Ballenger
A pilot study of vagus nerve stimulation (VNS) for treatment-resistant anxiety disorders.
Brain stimulation 2008;1(2):112-21.
2008: Robert H Howland
Neurosurgical approaches to therapeutic brain stimulation for treatment-resistant depression.
Journal of psychosocial nursing and mental health services 2008;46(4):15-9.
2008: Robert H Howland
How are drugs approved? Part 3. The stages of drug development.
Journal of psychosocial nursing and mental health services 2008;46(3):17-20.
2008: Robert H Howland
How are drugs approved? Part 2: ethical foundations of clinical research.
Journal of psychosocial nursing and mental health services 2008;46(2):15-20.
2008: Robert H Howland; Pamela J Schettler; Mark Hyman Rapaport; David Mischoulon; Trisha Schneider; Amy Fasiczka; Katia Delrahiem; Rachel Maddux; Michael Lightfoot; Andrew A Nierenberg
Clinical features and functioning of patients with minor depression.
Psychotherapy and psychosomatics 2008;77(6):384-9.
2008: Robert H Howland
How are drugs approved? Part 1: the evolution of the Food and Drug Administration.
Journal of psychosocial nursing and mental health services 2008;46(1):15-9.
2007: Robert H Howland
Agomelatine: a novel atypical antidepressant.
Journal of psychosocial nursing and mental health services 2007;45(12):13-7.
2007: Madhukar H Trivedi; A John Rush; Bradley N Gaynes; Jonathan W Stewart; Stephen R Wisniewski; Diane Warden; Louise Ritz; James F Luther; Diane Stegman; Joanne Deveaugh-Geiss; Robert H Howland
Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 2007;32(12):2479-89.
2007: Robert H Howland
Limitations of evidence in the practice of evidence-based medicine.
Journal of psychosocial nursing and mental health services 2007;45(11):13-6.
2007: Robert H Howland
Medication adherence.
Journal of psychosocial nursing and mental health services 2007;45(9):15-9.
2007: Robert H Howland
Lithium: underappreciated and underused?
Journal of psychosocial nursing and mental health services 2007;45(8):13-7.
2007: Diane Warden; Madhukar H Trivedi; Stephen R Wisniewski; Lori Davis; Andrew A Nierenberg; Bradley N Gaynes; Sidney Zisook; Steven D Hollon; Balasubramani G.K.; Robert H Howland; Maurizio Fava; Jonathan W Stewart; A John Rush
Predictors of attrition during initial (citalopram) treatment for depression: a STAR*D report.
The American journal of psychiatry 2007;164(8):1189-97.
2007: Robert H Howland
Antidepressants & suicide: putting the risk in perspective.
Journal of psychosocial nursing and mental health services 2007;45(7):15-9.
2007: Robert H Howland
Pharmacotherapy in personality disorders.
Journal of psychosocial nursing and mental health services 2007;45(6):15-9.
2007: Robert H Howland
Paliperidone extended-release tablets: a new atypical antipsychotic.
Journal of psychosocial nursing and mental health services 2007;45(5):15-8.
2007: Robert H Howland
Unusual & serious adverse effects of SSRIs: recognition & management.
Journal of psychosocial nursing and mental health services 2007;45(3):15-8.
2007: Robert H Howland
Managing common Side effects of SSRIs.
Journal of psychosocial nursing and mental health services 2007;45(2):15-8.
2007: Robert H Howland
Glutamate-modulating drugs & the treatment of mental disorders.
Journal of psychosocial nursing and mental health services 2007;45(1):11-4.
2006: Robert H Howland
Pharmacotherapy for psychotic depression.
Journal of psychosocial nursing and mental health services 2006;44(12):13-7.
2006: Robert H Howland
Pharmacotherapy strategies for treatment-resistant depression.
Journal of psychosocial nursing and mental health services 2006;44(11):11-4.
2006: Robert H Howland
Electroencephalography technology for predicting response to antidepressant medications.
Journal of psychosocial nursing and mental health services 2006;44(10):11-4.
2006: Robert H Howland
Vagus nerve stimulation for depression and other neuropsychiatric disorders.
Journal of psychosocial nursing and mental health services 2006;44(9):11-4.
2006: Robert H Howland
What is vagus nerve stimulation?
Journal of psychosocial nursing and mental health services 2006;44(8):11-4.
2006: Robert H Howland
Transdermal selegiline: a novel MAOI formulation for depression.
Journal of psychosocial nursing and mental health services 2006;44(7):9-12.
2006: Robert H Howland
MAOI antidepressant drugs.
Journal of psychosocial nursing and mental health services 2006;44(6):9-12.
2006: Robert H Howland
Challenges in the diagnosis & treatment of bipolar depression--part 2: treatment options.
Journal of psychosocial nursing and mental health services 2006;44(5):9-12.
2006: Robert H Howland
Challenges in the diagnosis & treatment of bipolar depression--Part 1: assessment.
Journal of psychosocial nursing and mental health services 2006;44(4):9-12.
2006: Robert H Howland
Principles & practice of polypharmacotherapy.
Journal of psychosocial nursing and mental health services 2006;44(3):13-6.
2006: Robert H Howland
Personalized drug therapy with pharmacogenetics--part 2: pharmacodynamics.
Journal of psychosocial nursing and mental health services 2006;44(2):13-6.
2006: Robert H Howland
Personalized drug therapy with pharmacogenetics. Part 1: Pharmacokinetics.
Journal of psychosocial nursing and mental health services 2006;44(1):13-6.
2006: Madhukar H Trivedi; A John Rush; Stephen R Wisniewski; Andrew A Nierenberg; Diane Warden; Louise Ritz; Grayson Norquist; Robert H Howland; Barry D Lebowitz; Patrick J McGrath; Kathy Shores-Wilson; Melanie Biggs; Balasubramani G.K.; Maurizio Fava
Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: implications for clinical practice.
The American journal of psychiatry 2006;163(1):28-40.
2005: Robert H Howland
Pharmacotherapy for insomnia.
Journal of psychosocial nursing and mental health services 2005;43(12):13-6.
2005: Robert H Howland
Atypical antipsychotics: special formulations for acute agitation.
Journal of psychosocial nursing and mental health services 2005;43(10):14-7.
2005: Mark Stork George; A John Rush; Lauren B Marangell; Harold A Sackeim; Stephen K Brannan; Sonia M Davis; Robert H Howland; Mitchel A Kling; Francisco Moreno; Barry R Rittberg; David L Dunner; Thomas Schwartz; Linda Carpenter; Michael Burke; Philip T Ninan; Paul Goodnick
A one-year comparison of vagus nerve stimulation with treatment as usual for treatment-resistant depression.
Biological psychiatry 2005;58(5):364-73.
2005: A John Rush; Harold A Sackeim; Lauren B Marangell; Mark Stork George; Stephen K Brannan; Sonia M Davis; Philip W Lavori; Robert H Howland; Mitchel A Kling; Barry R Rittberg; Linda Carpenter; Philip T Ninan; Francisco Moreno; Thomas Schwartz; Charles Conway; Michael Burke; John J Barry
Effects of 12 months of vagus nerve stimulation in treatment-resistant depression: a naturalistic study.
Biological psychiatry 2005;58(5):355-63.
2005: A John Rush; Lauren B Marangell; Harold A Sackeim; Mark Stork George; Stephen K Brannan; Sonia M Davis; Robert H Howland; Mitchel A Kling; Barry R Rittberg; William J Burke; Mark H Rapaport; John M Zajecka; Andrew A Nierenberg; Mustafa M Husain; David Ginsberg; Robert G Cooke
Vagus nerve stimulation for treatment-resistant depression: a randomized, controlled acute phase trial.
Biological psychiatry 2005;58(5):347-54.
2005: Robert H Howland
Use of atypical antipsychotics in children and adolescents.
Journal of psychosocial nursing and mental health services 2005;43(8):15-8.
2005: Robert H Howland
Anticonvulsant drug therapies.
Journal of psychosocial nursing and mental health services 2005;43(6):17-20.
2005: Alan F Schatzberg; A John Rush; Bruce A Arnow; Phillip L C Banks; Janice A Blalock; Frances E Borian; Robert H Howland; Daniel N Klein; James H Kocsis; Susan G Kornstein; Rachel Manber; John Markowitz; Ivan Miller; Philip T Ninan; Barbara O Rothbaum; Michael E Thase; Madhukar H Trivedi; Martin B Keller
Chronic depression: medication (nefazodone) or psychotherapy (CBASP) is effective when the other is not.
Archives of general psychiatry 2005;62(5):513-20.
2005: Robert H Howland
Herbal therapies.
Journal of psychosocial nursing and mental health services 2005;43(4):16-9.
2005: Robert H Howland
Therapeutic brain stimulation for mental disorders.
Journal of psychosocial nursing and mental health services 2005;43(2):16-9.
2003: Ripu D Jindal; Edward S Friedman; Susan R Berman; Amy L Fasiczka; Robert H Howland; Michael E Thase
Effects of sertraline on sleep architecture in patients with depression.
Journal of clinical psychopharmacology 2003;23(6):540-8.
2003: James P McCullough; Daniel N Klein; Frances E Borian; Robert H Howland; Lawrence P Riso; Martin B Keller; Phillip L C Banks
Group comparisons of DSM-IV subtypes of chronic depression: validity of the distinctions, part 2.
Journal of abnormal psychology 2003;112(4):614-22.
2003: Alan J Gelenberg; Madhukar H Trivedi; A John Rush; Michael E Thase; Robert H Howland; Daniel N Klein; Susan G Kornstein; David L Dunner; John Markowitz; Robert M A Hirschfeld; Gabor I Keitner; John M Zajecka; James H Kocsis; James M Russell; Ivan Miller; Rachel Manber; Bruce A Arnow; Barbara O Rothbaum; Melvin Munsaka; Phillip Banks; Frances E Borian; Martin B Keller
Randomized, placebo-controlled trial of nefazodone maintenance treatment in preventing recurrence in chronic depression.
Biological psychiatry 2003;54(8):806-17.
2002: James H Kocsis; Alan F Schatzberg; A John Rush; Daniel N Klein; Robert H Howland; Leah Gniwesch; Sonia M Davis; Wilma Harrison
Psychosocial outcomes following long-term, double-blind treatment of chronic depression with sertraline vs placebo.
Archives of general psychiatry 2002;59(8):723-8.
2002: Michael E Thase; A John Rush; Robert H Howland; Susan G Kornstein; James H Kocsis; Alan J Gelenberg; Alan F Schatzberg; Lorrin M Koran; Martin B Keller; James M Russell; Robert M A Hirschfeld; Lisa M LaVange; Daniel N Klein; Jan Fawcett; Wilma Harrison
Double-blind switch study of imipramine or sertraline treatment of antidepressant-resistant chronic depression.
Archives of general psychiatry 2002;59(3):233-9.
2001: Lorrin M Koran; Alan J Gelenberg; Susan G Kornstein; Robert H Howland; R A Friedman; Charles DeBattista; D Klein; James H Kocsis; Alan F Schatzberg; Michael E Thase; A John Rush; Robert M A Hirschfeld; Lisa M LaVange; Martin B Keller
Sertraline versus imipramine to prevent relapse in chronic depression.
Journal of affective disorders 2001;65(1):27-36.
2001: Michael E Thase; Edward S Friedman; Robert H Howland
Management of treatment-resistant depression: psychotherapeutic perspectives.
The Journal of clinical psychiatry 2001;62 Suppl 18():18-24.
2000: James P McCullough; Daniel N Klein; Martin B Keller; Charles Holzer; Sonia M Davis; Susan G Kornstein; Robert H Howland; Michael E Thase; Wilma M Harrison
Comparison of DSM-III-R chronic major depression and major depression superimposed on dysthymia (double depression): validity of the distinction.
Journal of abnormal psychology 2000;109(3):419-27.
2000: Michael E Thase; Edward S Friedman; Robert H Howland
Venlafaxine and treatment-resistant depression.
Depression and anxiety 2000;12 Suppl 1():55-62.
2000: Michael E Thase; Edward S Friedman; Susan R Berman; Amy L Fasiczka; J A Lis; Robert H Howland; AD Simons
Is cognitive behavior therapy just a 'nonspecific' intervention for depression? A retrospective comparison of consecutive cohorts treated with cognitive behavior therapy or supportive counseling and pill placebo.
Journal of affective disorders 2000;57(1-3):63-71.
1999: Daniel N Klein; Alan F Schatzberg; James P McCullough; F Dowling; D Goodman; Robert H Howland; John Markowitz; C Smith; Michael E Thase; A John Rush; Lisa M LaVange; Wilma M Harrison; Martin B Keller
Age of onset in chronic major depression: relation to demographic and clinical variables, family history, and treatment response.
Journal of affective disorders 1999;55(2-3):149-57.
1999: Daniel N Klein; Alan F Schatzberg; James P McCullough; Martin B Keller; F Dowling; D Goodman; Robert H Howland; John Markowitz; C Smith; RJ Miceli; Wilma M Harrison
Early- versus late-onset dythymic disorder: comparison in out-patients with superimposed major depressive episodes.
Journal of affective disorders 1999;52(1-3):187-96.
1998: Robert M A Hirschfeld; James M Russell; Pedro Delgado; Jan Fawcett; R A Friedman; Wilma M Harrison; Lorrin M Koran; Ivan W Miller; Michael E Thase; Robert H Howland; M A Connolly; RJ Miceli
Predictors of response to acute treatment of chronic and double depression with sertraline or imipramine.
The Journal of clinical psychiatry 1998;59(12):669-75.
1998: Michael E Thase; Robert H Howland; Edward S Friedman
Treating antidepressant nonresponders with augmentation strategies: an overview.
The Journal of clinical psychiatry 1998;59 Suppl 5():5-12; discussion 13-5.
1997: Robert H Howland
Pharmacotherapy of inpatients with bipolar depression.
Annals of clinical psychiatry : official journal of the American Academy of Clinical Psychiatrists 1997;9(4):199-202.
1997: Lawrence P Riso; Michael E Thase; Robert H Howland; Edward S Friedman; AD Simons; XM Tu
A prospective test of criteria for response, remission, relapse, recovery, and recurrence in depressed patients treated with cognitive behavior therapy.
Journal of affective disorders 1997;43(2):131-42.
1993: Robert H Howland; Michael E Thase
A comprehensive review of cyclothymic disorder.
The Journal of nervous and mental disease 1993;181(8):485-93.
1993: Robert H Howland
Thyroid dysfunction in refractory depression: implications for pathophysiology and treatment.
The Journal of clinical psychiatry 1993;54(2):47-54.
1992: Robert H Howland
Fluoxetine treatment of depression in mentally retarded adults.
The Journal of nervous and mental disease 1992;180(3):202-5.